Latest by Myles Helfand

This Week in HIV Research: The PrEP Sex/Race Gap

PrEP access appears far from equal in the U.S.; HIV treatment and viral suppression disparities in Europe; how today’s hepatitis C treatments affect mortality; sex-based differences in cognitive impairment.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Gender Disparities Among the Formerly Incarcerated

Post-incarceration HIV outcomes worse among women; no drug resistance despite apparent PrEP failure; cost-efficacy of adherence self-management; additional cancers in HIV-positive cancer survivors.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: A New Frontier in Organ Transplantation

HIV-positive donor, HIV-negative recipient; continuum of care after incarceration in U.S.; reduced bone mineral density among men with HIV under 50; discouraging anti-inflammatory findings for an antiplatelet agent.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: The Case for Pre-Pregnancy Treatment

The benefits of pre-pregnancy HIV treatment initiation for mothers-to-be; HIV diagnoses rise among young U.S. MSM; cost effectiveness of PrEP for heterosexual women; methotrexate and arterial function.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Food, It Does a Body Good

How food insecurity feeds inflammation; racial disparities in HPV16 prevalence; how HIV meds affect pre-existing neurocognitive impairment; central nervous system inflammation in the setting of HIV treatment success.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Pain, Opioids, and Viral Suppression

Why not all opioid prescriptions are unwise; racial, gender, age, and risk group disparities in HIV care; prophylactic antibiotic use rises among MSM on PrEP; navigating ambiguous HIV test results among PrEP users.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: How Antiretrovirals May Affect Birth

The effect of specific regimens on some birth-related events; obstacles to PrEP among U.S. women; improving mortality and treatment success for HIV-positive people who inject drugs; kidney disease and “old” tenofovir.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Matters of the Mind

Anticholinergics and cognitive performance; gender, physical activity, and cognitive decline; how peer networks can boost HIV self-testing among MSM of color; what HIV care providers don’t know about the Affordable Care Act.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Where Are the Cervical Cancer Screens?

Poor rates of cervical cancer screening for women of color; interest vs. action among potential organ donors; an online depression intervention; Truvada levels in men’s vs. women’s hair.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Gendered Nuances in Care and Complications

Alcohol use worsens HIV care outcomes; sex-based differences in cognitive performance seen; higher cardiovascular risk among trans women; glycemic status related to cognitive function.

By Barbara Jungwirth and Myles Helfand